RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: Global Harmonization Initiatives

In Focus: Global Harmonization Initiatives

Posted 01 March 2010 | By

The steadily increasing push for drug and device regulatory harmonization worldwide has been driven by many factors, not the least of them economic. It is no longer possible for a country to exist in a bubble, unconcerned about socioeconomic, political and regulatory developments in faraway regions. Neither is it feasible for a pharmaceutical or medical device company to ignore the regulatory infrastructure and requirements of other countries simply because it is not currently importing into or exporting from these areas. This situation could change rapidly.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.